These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31771450)

  • 1. Mathematical modelling identifies the role of adaptive immunity as a key controller of respiratory syncytial virus in cotton rats.
    Wethington D; Harder O; Uppulury K; Stewart WCL; Chen P; King T; Reynolds SD; Perelson AS; Peeples ME; Niewiesk S; Das J
    J R Soc Interface; 2019 Nov; 16(160):20190389. PubMed ID: 31771450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Acquired Immunity following Repeated Respiratory Syncytial Virus Infections in Cotton Rats.
    Yamaji Y; Yasui Y; Nakayama T
    PLoS One; 2016; 11(5):e0155777. PubMed ID: 27224021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A viral-vectored RSV vaccine induces long-lived humoral immunity in cotton rats.
    Grieves JL; Yin Z; Garcia-Sastre A; Mena I; Peeples ME; Risman HP; Federman H; Sandoval MJ; Durbin RK; Durbin JE
    Vaccine; 2018 Jun; 36(26):3842-3852. PubMed ID: 29779923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease.
    Hwang HS; Lee YT; Kim KH; Park S; Kwon YM; Lee Y; Ko EJ; Jung YJ; Lee JS; Kim YJ; Lee YN; Kim MC; Cho M; Kang SM
    Virology; 2016 Jul; 494():215-24. PubMed ID: 27123586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic difference of respiratory syncytial virus infection in cotton rats of different ages.
    Wen X; Mo S; Chen S; Yu G; Gao L; Chen S; Deng Y; Xie X; Zang N; Ren L; Liu E
    Microb Pathog; 2019 Dec; 137():103749. PubMed ID: 31521801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats.
    Widjojoatmodjo MN; Bogaert L; Meek B; Zahn R; Vellinga J; Custers J; Serroyen J; Radošević K; Schuitemaker H
    Vaccine; 2015 Oct; 33(41):5406-5414. PubMed ID: 26319741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant measles viruses expressing respiratory syncytial virus proteins induced virus-specific CTL responses in cotton rats.
    Yamaji Y; Nakayama T
    Vaccine; 2014 Jul; 32(35):4529-4536. PubMed ID: 24951869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats.
    Kamphuis T; Shafique M; Meijerhof T; Stegmann T; Wilschut J; de Haan A
    Vaccine; 2013 Apr; 31(17):2169-76. PubMed ID: 23499594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cotton rat lung transcriptome reveals host immune response to Respiratory Syncytial Virus infection.
    Rajagopala SV; Singh H; Patel MC; Wang W; Tan Y; Shilts MH; Hartert TV; Boukhvalova MS; Blanco JCG; Das SR
    Sci Rep; 2018 Jul; 8(1):11318. PubMed ID: 30054492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and Chronic Airway Disease After Human Respiratory Syncytial Virus Infection in Cotton Rats (Sigmodon hispidus).
    Grieves JL; Yin Z; Durbin RK; Durbin JE
    Comp Med; 2015 Aug; 65(4):315-26. PubMed ID: 26310461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable Attenuation of Human Respiratory Syncytial Virus for Live Vaccines by Deletion and Insertion of Amino Acids in the Hinge Region between the mRNA Capping and Methyltransferase Domains of the Large Polymerase Protein.
    Xue M; Wang R; Harder O; Chen P; Lu M; Cai H; Li A; Liang X; Jennings R; La Perle K; Niewiesk S; Peeples ME; Li J
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental animal model for analyzing immunobiological responses following vaccination with formalin-inactivated respiratory syncytial virus.
    Sawada A; Nakayama T
    Microbiol Immunol; 2016 Apr; 60(4):234-42. PubMed ID: 26865035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unveiling Integrated Functional Pathways Leading to Enhanced Respiratory Disease Associated With Inactivated Respiratory Syncytial Viral Vaccine.
    Russell MS; Creskey M; Muralidharan A; Li C; Gao J; Chen W; Larocque L; Lavoie JR; Farnsworth A; Rosu-Myles M; Hashem AM; Yauk CL; Cao J; Van Domselaar G; Cyr T; Li X
    Front Immunol; 2019; 10():597. PubMed ID: 30984178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
    Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
    Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related differences in pulmonary cytokine response to respiratory syncytial virus infection: modulation by anti-inflammatory and antiviral treatment.
    Boukhvalova MS; Yim KC; Kuhn KH; Hemming JP; Prince GA; Porter DD; Blanco JC
    J Infect Dis; 2007 Feb; 195(4):511-8. PubMed ID: 17230410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats.
    O'Konek JJ; Makidon PE; Landers JJ; Cao Z; Malinczak CA; Pannu J; Sun J; Bitko V; Ciotti S; Hamouda T; Wojcinski ZW; Lukacs NW; Fattom A; Baker JR
    Hum Vaccin Immunother; 2015; 11(12):2904-12. PubMed ID: 26307915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of respiratory syncytial virus (RSV) infection and development of RSV-specific IgG1 response in a guinea-pig model of acute bronchiolitis.
    Dakhama A; Vitalis TZ; Hegele RG
    Eur Respir J; 1997 Jan; 10(1):20-6. PubMed ID: 9032486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon.
    Piedra PA; Wyde PR; Castleman WL; Ambrose MW; Jewell AM; Speelman DJ; Hildreth SW
    Vaccine; 1993 Nov; 11(14):1415-23. PubMed ID: 7508665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.